VAERS reports by lot

GSK DTaP/Tdap lot 9ZK5T: VAERS reports

28 VAERS reports list lot 9ZK5T as a GSK DTaP/Tdap vaccine, received between 2022-08-30 and 2024-05-03. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
28
Reports
0%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological1441%
Cardiac / Cardiovascular515%
Musculoskeletal515%
Injection-site / Local reaction412%
General / Systemic (non-local)26%
Autoimmune / Immune-mediated13%
Allergic / Anaphylactic13%
Gastrointestinal13%
Dermatological (non-injection-site)13%

Where reports came from

U.S. state of the reporter, where given (top 12).

Missouri4
New Jersey3
Wisconsin3
Ohio2
Maine2
Georgia2
Illinois1
Iowa1
Arizona1
North Carolina1
Colorado1
Nevada1

Reports by month received

2022-081
2022-092
2022-106
2022-116
2022-124
2023-011
2023-021
2023-032
2023-051
2023-062
2023-121
2024-051

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.